News

Alphyn's Zabalafin Hydrogel for Atopic Dermatitis Highlighted in Leading Peer-Reviewed Journal
Alphyn Biologics, Inc., a clinical-stage dermatology company developing first-in-class Multi-Target Therapeutics®, announced ...